Analytical Data
-
基因名
WIF-1
- Application
-
种属
Rat
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6IN38
-
表达区间
Leu38~Ser247
-
分子量
27kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WIF-1 (Wnt Inhibitory Factor-1) is a secreted protein that plays a critical role in the regulation of the Wnt signaling pathway, which is essential for various developmental processes and cell proliferation. Abnormal activation of Wnt signaling is associated with multiple cancers, making WIF-1 an important molecule for potential therapeutic applications. Research has highlighted that WIF-1 can antagonize Wnt signaling by binding to Wnt ligands, thereby preventing their interaction with Frizzled receptors. Understanding the structure and function of WIF-1 has significant implications for targeted cancer therapies and regenerative medicine, as it may provide insights into mechanisms of tumor suppression and tissue repair. Recent studies have focused on the recombinant expression of WIF-1 to establish its functional characteristics and properties. This involves leveraging advanced molecular biology techniques to produce WIF-1 in host systems, allowing for detailed biochemical analyses and the exploration of its therapeutic potential. Ongoing research also aims to elucidate the role of WIF-1 in various biological contexts, including its implications in embryonic development and tissue homeostasis. As a candidate for biomarker development and a target for therapeutic intervention, WIF-1 continues to be an area of intense study, with the hope of translating these findings into clinical applications for cancer treatment and regenerative medicine.
